{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:41:07Z","timestamp":1787496067507,"version":"build-2736575974"},"reference-count":105,"publisher":"Annals of Laboratory Medicine","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19-fk0210025h0003"],"award-info":[{"award-number":["JP19-fk0210025h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19-fk0210025h0003"],"award-info":[{"award-number":["JP19-fk0210025h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annlabmed.org"],"crossmark-restriction":true},"short-container-title":["Ann Lab Med"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.3343\/alm.2021.41.1.16","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T01:40:08Z","timestamp":1598233208000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.3343\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases"],"prefix":"10.3343","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-6616","authenticated-orcid":false,"given":"Nobuharu","family":"Tamaki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan"},{"name":"NAFLD Research Center, Division of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-8931","authenticated-orcid":false,"given":"Masayuki","family":"Kurosaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-9991","authenticated-orcid":false,"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Division of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-8229","authenticated-orcid":false,"given":"Namiki","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27150","reference":[{"key":"ref1","volume-title":"The role of liver biopsy in chronic hepatitis C","author":"Dienstag","year":"2002"},{"key":"ref2","volume-title":"Role of liver biopsy in management of chronic hepatitis C: a systematic review","author":"Gebo","year":"2002"},{"key":"ref3","first-page":"1207","volume-title":"Assessment of hepatic fibrosis with magnetic resonance elastography","author":"Yin","year":"2007"},{"key":"ref4","first-page":"1920","volume-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","author":"Loomba","year":"2014"},{"key":"ref5","first-page":"893","volume-title":"Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals","author":"Tamaki","year":"2019"},{"key":"ref6","first-page":"2616","volume-title":"Prediction of hepatocellular carcinoma after sustained virological responses using magnetic resonance elastography","author":"Higuchi","year":"2019"},{"key":"ref7","first-page":"835","volume-title":"Non-invasive evaluation of liver fibrosis using transient elastography","author":"Castera","year":"2008"},{"key":"ref8","first-page":"720","volume-title":"Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients","author":"Tamaki","year":"2014"},{"key":"ref9","first-page":"515","volume-title":"Diagnosis of fibrosis and activity by a combined use of strain and shear wave imaging in patients with liver disease","author":"Yada","year":"2017"},{"key":"ref10","first-page":"1343","volume-title":"Advances in non-invasive assessment of hepatic fibrosis","author":"Loomba","year":"2020"},{"key":"ref11","first-page":"849","volume-title":"Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease","author":"Ajmera","year":"2020"},{"key":"ref12","first-page":"31121","volume-title":"Multicenter validation of association between decline in MRI-PDFF and histologic response in nonalcoholic steatohepatitis","author":"Loomba","year":"2020"},{"key":"ref13","first-page":"821","volume-title":"Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method","author":"Tamaki","year":"2018"},{"key":"ref14","first-page":"1317","volume-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","author":"Sterling","year":"2006"},{"key":"ref15","first-page":"72","volume-title":"Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C","author":"Tamaki","year":"2013"},{"key":"ref16","first-page":"1495","volume-title":"Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients","author":"Tamaki","year":"2014"},{"key":"ref17","first-page":"667","volume-title":"Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications","author":"Takahashi","year":"2015"},{"key":"ref18","first-page":"1264","volume-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","author":"Castera","year":"2019"},{"key":"ref19","first-page":"1065","volume-title":"A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis","author":"Kuno","year":"2013"},{"key":"ref20","first-page":"819","volume-title":"Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis","author":"Shirabe","year":"2018"},{"key":"ref21","first-page":"1922","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: a meta-analysis","author":"Ito","year":"2017"},{"key":"ref22","first-page":"331","volume-title":"Usefulness of enhanced liver fibrosis, glycosylation isomer of Mac-2 binding protein, galectin-3, and soluble suppression of tumorigenicity 2 for assessing liver fibrosis in chronic liver diseases","author":"Moon","year":"2018"},{"key":"ref23","first-page":"76","volume-title":"A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis","author":"Toshima","year":"2015"},{"key":"ref24","first-page":"949","volume-title":"Novel biomarkers of hepatitis B and hepatocellular carcinoma: clinical significance of HBcrAg and M2BPGi","author":"Baudi","year":"2020"},{"key":"ref25","first-page":"181","volume-title":"Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods","author":"Yoneda","year":"2018"},{"key":"ref26","first-page":"33","volume-title":"Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection","author":"Yasui","year":"2019"},{"key":"ref27","first-page":"18731","volume-title":"Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin","author":"Rosenberg","year":"1991"},{"key":"ref28","first-page":"683","volume-title":"Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis\/cirrhosis diagnostics","author":"Narimatsu","year":"2015"},{"key":"ref29","first-page":"642","volume-title":"Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling","author":"Kuno","year":"2013"},{"key":"ref30","first-page":"1387","volume-title":"Hepatic stellate cells secreting WFA<sup>+<\/sup>-M2BP: its role in biological interactions with Kupffer cells","author":"Bekki","year":"2017"},{"key":"ref31","first-page":"1563","volume-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","author":"Yamasaki","year":"2014"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.12466","volume-title":"Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients","author":"Tamaki","year":"2015"},{"key":"ref33","first-page":"114","volume-title":"Serum WFA(+)-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C","author":"Ura","year":"2016"},{"key":"ref34","first-page":"394","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients","author":"Huang","year":"2017"},{"key":"ref35","first-page":"267","volume-title":"Fibrosis staging using direct serum biomarkers is influenced by hepatitis activity grading in hepatitis C virus infection","author":"Fujita","year":"2018"},{"key":"ref36","first-page":"177","volume-title":"Clinical evaluation of hepatocarcinogenesis and outcome using a novel glycobiomarker Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP) in chronic hepatitis C with advanced fibrosis","author":"Inoue","year":"2018"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177302","volume-title":"Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis","author":"Nakamura","year":"2017"},{"key":"ref38","first-page":"62","volume-title":"Accuracy of M2BPGi, compared with Fibro Scan\u00ae, in analysis of liver fibrosis in patients with hepatitis C","author":"Xu","year":"2017"},{"key":"ref39","first-page":"183","volume-title":"A glycomarker for short-term prediction of hepatocellular carcinoma: a longitudinal study with serial measurements","author":"Lin","year":"2018"},{"key":"ref40","first-page":"1142","volume-title":"Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group","author":"Tsuji","year":"2018"},{"key":"ref41","first-page":"356","volume-title":"Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals","author":"Izumi","year":"2018"},{"key":"ref42","first-page":"746","volume-title":"Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis","author":"Fujii","year":"2018"},{"key":"ref43","first-page":"264","volume-title":"Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group","author":"Akahane","year":"2019"},{"key":"ref44","first-page":"2143","volume-title":"Prediction of hepatocellular carcinoma development after hepatitis C virus eradication using serum Wisteria floribunda agglutinin-positive Mac-2-Binding protein","author":"Sato","year":"2016"},{"key":"ref45","first-page":"956","volume-title":"Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy","author":"Nagata","year":"2016"},{"key":"ref46","first-page":"758","volume-title":"Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients","author":"Miyaki","year":"2016"},{"key":"ref47","first-page":"1252","volume-title":"Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury","author":"Morio","year":"2017"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129053","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response","author":"Sasaki","year":"2015"},{"key":"ref49","first-page":"933","volume-title":"Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C","author":"Nagata","year":"2017"},{"key":"ref50","first-page":"1131","volume-title":"Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus","author":"Yasui","year":"2018"},{"key":"ref51","first-page":"1463","volume-title":"Complex association of virus- and host-related factors with hepatocellular carcinoma rate following hepatitis C virus clearance","author":"Akuta","year":"2019"},{"key":"ref52","first-page":"204","volume-title":"Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naive chronic hepatitis B","author":"Ishii","year":"2017"},{"key":"ref53","first-page":"226","volume-title":"Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection","author":"Ichikawa","year":"2017"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220663","volume-title":"Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients","author":"Yeh","year":"2019"},{"key":"ref55","first-page":"348","volume-title":"Diagnosis of liver fibrosis with Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) among chronic hepatitis B patients","author":"Jekarl","year":"2018"},{"key":"ref56","first-page":"163","volume-title":"Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection","author":"Mak","year":"2018"},{"key":"ref57","first-page":"24","volume-title":"M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with hepatitis B virus infection","author":"Wei","year":"2018"},{"key":"ref58","first-page":"493","volume-title":"Mac-2 binding protein glycosylation isomer as a hepatocellular carcinoma marker in patients with chronic hepatitis B or C infection","author":"Jun","year":"2019"},{"key":"ref59","first-page":"977","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study","author":"Nishikawa","year":"2016"},{"key":"ref60","first-page":"872","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma","author":"Chuaypen","year":"2018"},{"key":"ref61","first-page":"47507","volume-title":"Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment","author":"Cheung","year":"2017"},{"key":"ref62","first-page":"14352","volume-title":"Serum levels of M2BPGi as short-term predictors of hepatocellular carcinoma in untreated chronic hepatitis B patients","author":"Liu","year":"2017"},{"key":"ref63","first-page":"879","volume-title":"Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development","author":"Kim","year":"2017"},{"key":"ref64","first-page":"1817","volume-title":"Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients","author":"Mak","year":"2019"},{"key":"ref65","first-page":"740","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B","author":"Kawaguchi","year":"2018"},{"key":"ref66","first-page":"883","volume-title":"High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues","author":"Shinkai","year":"2018"},{"key":"ref67","first-page":"589","volume-title":"Serum Mac-2-Binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B-related cirrhosis","author":"Su","year":"2020"},{"key":"ref68","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003328","volume-title":"Use of Wisteria floribunda agglutinin-positive human Mac-2 binding protein in assessing risk of hepatocellular carcinoma due to hepatitis B virus","author":"Heo","year":"2016"},{"key":"ref69","first-page":"1398","volume-title":"Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients","author":"Mak","year":"2019"},{"key":"ref70","first-page":"1128","volume-title":"Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B","author":"Hsu","year":"2018"},{"key":"ref71","first-page":"776","volume-title":"Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease","author":"Abe","year":"2015"},{"key":"ref72","first-page":"1795","volume-title":"Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease","author":"Ogawa","year":"2018"},{"key":"ref73","first-page":"1194","volume-title":"Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis","author":"Nishikawa","year":"2016"},{"key":"ref74","first-page":"424","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein","author":"Atsukawa","year":"2018"},{"key":"ref75","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis","author":"Alkhouri","year":"2018"},{"key":"ref76","first-page":"1545","volume-title":"Correlations of hepatic hemodynamics, liver function, and fibrosis markers in nonalcoholic fatty liver disease: comparison with chronic hepatitis related to hepatitis C virus","author":"Shigefuku","year":"2016"},{"key":"ref77","first-page":"1216","volume-title":"The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study","author":"Ishiba","year":"2018"},{"key":"ref78","first-page":"10109","volume-title":"Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease","author":"Tamaki","year":"2019"},{"key":"ref79","first-page":"521","volume-title":"Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease","author":"Kawanaka","year":"2018"},{"key":"ref80","first-page":"549","volume-title":"Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis","author":"Kanno","year":"2019"},{"key":"ref81","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23316","volume-title":"Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups","author":"Nah","year":"2020"},{"key":"ref82","first-page":"1083","volume-title":"Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis","author":"Hanai","year":"2015"},{"key":"ref83","first-page":"1889","volume-title":"Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis","author":"Uojima","year":"2018"},{"key":"ref84","first-page":"242","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis","author":"Xu","year":"2018"},{"key":"ref85","first-page":"173","volume-title":"Use of the serum Wisteria floribunda agglutinin-positive Mac2 binding protein as a marker of gastroesophageal varices and liver-related events in chronic hepatitis C patients","author":"Hayashi","year":"2020"},{"key":"ref86","first-page":"5651","volume-title":"Prognostic role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level in early stage hepatocellular carcinoma","author":"Lin","year":"2020"},{"key":"ref87","first-page":"515","volume-title":"Elevation of Mac-2 binding protein glycosylation isomer after hepatectomy is associated with post-hepatectomy liver failure, total Pringle time, and renal dysfunction","author":"Imai","year":"2019"},{"key":"ref88","first-page":"1398","volume-title":"Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma","author":"Ishii","year":"2019"},{"key":"ref89","first-page":"1201","volume-title":"Usefulness of Mac-2 binding protein glycosylation isomer for prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma","author":"Okuda","year":"2017"},{"key":"ref90","first-page":"405","volume-title":"Combination of Mac-2 binding protein glycosylation isomer and Up-To-seven criteria as a useful predictor for child-Pugh grade deterioration after transarterial chemoembolization for hepatocellular carcinoma","author":"Eso","year":"2019"},{"key":"ref91","first-page":"384","volume-title":"The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy","author":"Totani","year":"2016"},{"key":"ref92","first-page":"1134","volume-title":"Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma","author":"Fujiyoshi","year":"2015"},{"key":"ref93","first-page":"293","volume-title":"Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection","author":"Toyoda","year":"2016"},{"key":"ref94","first-page":"33","volume-title":"Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection","author":"Kim","year":"2020"},{"key":"ref95","first-page":"550","volume-title":"Risk factors for loss of skeletal muscle mass in patients with cirrhosis","author":"Sung","year":"2019"},{"key":"ref96","first-page":"1359","volume-title":"Significant correlation between grip strength and m2bpgi in patients with chronic liver Diseases","author":"Nishikawa","year":"2019"},{"key":"ref97","first-page":"613","volume-title":"Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis","author":"Nishikawa","year":"2016"},{"key":"ref98","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013450","volume-title":"Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis","author":"Migita","year":"2018"},{"key":"ref99","first-page":"857","volume-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis","author":"Umemura","year":"2015"},{"key":"ref100","first-page":"575","volume-title":"Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-gamma-inducible protein-10 in primary biliary cirrhosis","author":"Nishikawa","year":"2016"},{"key":"ref101","first-page":"1065","volume-title":"Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia","author":"Ueno","year":"2018"},{"key":"ref102","first-page":"418","volume-title":"Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation","author":"Yamada","year":"2019"},{"key":"ref103","first-page":"355","volume-title":"Usefulness of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in children with primary sclerosing cholangitis","author":"Umetsu","year":"2018"},{"key":"ref104","first-page":"3640","volume-title":"Wisteria floribunda agglutinin-positive Mac-2 binding protein but not \u03b1-fetoprotein as a long-term hepatocellular carcinoma predictor","author":"Osawa","year":"2020"},{"key":"ref105","first-page":"41","volume-title":"Peritransplant kinetics of Mac-2-binding protein glycosylation isomer levels in living donor liver transplantation: its implication of posttransplant small-for-size syndrome","author":"Uchiyama","year":"2019"}],"container-title":["Annals of Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annlabmed.org\/upload\/pdf\/alm-2021-41-1-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.annlabmed.org\/journal\/view.html?volume=41&number=1&spage=16","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.annlabmed.org\/upload\/pdf\/alm-2021-41-1-16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T01:42:27Z","timestamp":1696556547000},"score":1,"resource":{"primary":{"URL":"http:\/\/annlabmed.org\/journal\/view.html?doi=10.3343\/alm.2021.41.1.16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"alternative-id":["10.3343\/alm.2021.41.1.16"],"URL":"https:\/\/doi.org\/10.3343\/alm.2021.41.1.16","relation":{},"ISSN":["2234-3806","2234-3814"],"issn-type":[{"value":"2234-3806","type":"print"},{"value":"2234-3814","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]},"assertion":[{"value":"http:\/\/annlabmed.org\/journal\/view.html?doi=10.3343\/alm.2021.41.1.16","URL":"http:\/\/annlabmed.org\/journal\/view.html?doi=10.3343\/alm.2021.41.1.16","name":"the_journal","label":"Ann Lab Med","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2020-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2021 The Korean Society for Laboratory Medicine","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}